acridines has been researched along with Leukemia, Myeloid, Acute in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Augustin, E; Borowa-Mazgaj, B; Pelikant, I; Sankowska, E; Skwarska, A; Weryszko, A | 1 |
Beck, JF; Boer, R; Buchholz, F; Gekeler, V; Niethammer, D; Sanders, KH; Ulrich, WR | 1 |
Elgie, AW; Lewandowicz, GM; Sargent, JM; Taylor, CG; Williamson, CJ | 1 |
Abdulkadyrov, KM; Balashova, VA; Bubnova, LN; Glazanova, TV; Kovalenko, AL; Moiseev, SI; Pavlova, IE; Rozanova, OE | 1 |
Benjamin, RS; Bodey, GP; Burgess, MA; Gutterman, JU; Hall, SW; Legha, SS; Valdivieso, M | 1 |
Adams, LR; Kamentsky, LA; Melamed, MR; Traganos, F; Zimring, A | 1 |
1 trial(s) available for acridines and Leukemia, Myeloid, Acute
Article | Year |
---|---|
[Immunomodulator Cycloferon in the comprehensive treatment of patients with acute non-lymphoblastic leukemia].
Topics: Acridines; Adjuvants, Immunologic; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Interferon Inducers; Leukemia, Myeloid, Acute; Male; Middle Aged; Treatment Outcome | 1999 |
5 other study(ies) available for acridines and Leukemia, Myeloid, Acute
Article | Year |
---|---|
The antitumor compound triazoloacridinone C-1305 inhibits FLT3 kinase activity and potentiates apoptosis in mutant FLT3-ITD leukemia cells.
Topics: Acridines; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Proliferation; Dose-Response Relationship, Drug; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinases; Molecular Targeted Therapy; Mutation; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; RNA Interference; Signal Transduction; STAT5 Transcription Factor; Time Factors; Transfection; Triazoles; U937 Cells | 2015 |
Rhodamine 123 efflux modulation in the presence of low or high serum from CD56+ hematopoietic cells or CD34+ leukemic blasts by B9309-068, a newly designed pyridine derivative.
Topics: Acridines; Antigens, CD34; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Blood Proteins; Calcium Channel Blockers; CD56 Antigen; Cyclosporins; Dihydropyridines; Dose-Response Relationship, Drug; Flow Cytometry; Fluorescent Dyes; Gene Expression; Humans; Isoquinolines; Leukemia, Myeloid, Acute; Leukocytes, Mononuclear; Morpholines; Multidrug Resistance-Associated Proteins; Pyrimidines; Rhodamine 123; Rhodamines; Tetrahydroisoquinolines; Verapamil | 1998 |
Comparison of P-glycoprotein expression and function with in vitro sensitivity to anthracyclines in AML.
Topics: Acridines; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Bone Marrow; Cell Survival; Cyclosporine; Daunorubicin; Gene Expression Regulation, Neoplastic; Humans; Isoquinolines; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Recurrence; Tetrahydroisoquinolines; Tumor Cells, Cultured | 1999 |
Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivative.
Topics: Acridines; Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Bone Marrow; Drug Administration Schedule; Drug Evaluation; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Phenylenediamines; Remission, Spontaneous | 1978 |
Acridine orange metachromasia for characterization of leukocytes in leukemia, lymphoma, and other neoplasms.
Topics: Acridines; Breast Neoplasms; Cell Nucleus; Cytoplasm; Fluorescent Dyes; Fluorometry; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukocytes; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mycosis Fungoides; Neoplasms; Photometry; Polycythemia Vera; Staining and Labeling | 1972 |